Pharmaceutical Cold Chain Packaging Market Size, Share, Trends, Analysis To 2032

Pharmaceutical Cold Chain Packaging Market Insights

According to the report published by Zion Market Research, the global Pharmaceutical Cold Chain Packaging Market size was valued at USD 38.92 Billion in 2023 and is predicted to reach USD 154.49 Billion by the end of 2032. The market is expected to grow with a CAGR of 14.8% during the forecast period. The report analyzes the global Pharmaceutical Cold Chain Packaging Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Pharmaceutical Cold Chain Packaging industry.

Request Free Sample

Global Pharmaceutical Cold Chain Packaging Market: Overview

The cold chain is an arrangement of temperature-controlled surface transport and supply chain. The pharmaceutical cold chain logistics is primarily required for vaccines and drugs which need to be handled in temperature sensitive environments. As biopharmaceuticals are protein molecules whose efficacy can vary if not offered the right temperature all the time. In such cases, cold chain logistics is highly utilized. The market for pharmaceutical cold chain packaging is expected to rise significantly to make sure the risk of damage during shipment solution in packaging is less.    

Global Pharmaceutical Cold Chain Packaging Market: Growth Factors

The global pharmaceutical cold chain packaging market is expected to grow at rapid pace during the forecast period. Factors that are primarily influencing the growth of the market include rising demand for temperature sensitive medicines such as minerals, vitamins, supplements, among others. Also, benefits with long distance shipments without compromising the quality of the drugs is largely contributing towards growth of global pharmaceutical cold chain packaging market.. Along with this, substantial growth in pharmaceutical sector and increasing expenditure on it in developing as well as developed countries to keep the efficiency of drugs as it is throughout the process is a key growth prospect for cold chain packaging in pharmaceutical sector.. As there is an increase in development of complex bio-based medicines, shipment of proteins that need to be stored at cool chain refinements contributes to the growth of global pharmaceutical cold chain packaging market. However, high operational costs as rate of energy consumption in pharmaceutical cold chain packaging may not be affordable for low economic countries which may downgrade the growth of market. Other than that, lack of stabilization and regulations in low-income countries may also hinder the market presence.        

Due to the Covid-19 pandemic, medical sector witnessed most investment due to researches going all over the globe for vaccine invention and thus curbing the virus. Only few vaccines after clinical researches were approved for emergency use, for instance, Sputnik-V, Covishield, Covaxin, etc. It is said that by authorities that mRNA-based formulas have to be stored at an 80 degree Celsius, thus, for maintaining the efficiency, utilization of cold chain logistics witnessed significant growth. Also, demand for various temperature sensitive biological drugs during the pandemic also increased the need for cold chain logistics for supply and distribution.   

To know more about this report, request a sample copy.

Request Free Sample

Global Pharmaceutical Cold Chain Packaging Market: Segmentation

Market segments for pharmaceutical cold chain packaging include packaging format, product, material, application, end-use, and region.

The packaging format, is categorized into active and passive packaging.

The product, segment is split into small boxes, pallets, and large sized pallet containers.

The market based on material, is classified into polymer, metalsand paper.

The applications, of the pharmaceutical cold chain include biologics & biological samples, vaccines & diagnostics, and others.

The end-user, segment is divided into diagnostic centers, clinical research organizations, blood banks, the vaccines packaging industry, pharmaceuticals, and other healthcare units.

Pharmaceutical Cold Chain Packaging Market: Report Scope

Global Pharmaceutical Cold Chain Packaging Market: Regional Analysis

North America is anticipated to dominate the overall global pharmaceutical cold chain packaging market owing to the presence of the leading medical sector in terms of infrastructure as well as research and development. The US is expected to remain the major revenue contributor in the region. Factors such as technological advancements happening in the pharmaceutical cold chain packaging domain is likely to contribute towards its growth. Europe is expected to be the second largest market owing to increasing investments in research & development sector, presence of large biopharmaceutical companies and well-established logistic chain. Germany, the UK, and France are anticipated to generate healthy revenue in the European pharmaceutical cold chain packaging market.

Major factors such as availability of skilled people having knowledge of technological advancements and higher import & export rate of pharmaceutical drugs is expected to surge the market growth in Europe. Asia Pacific is also projected to register healthy growth during the forecast period, where China is the largest market as there has been an increase in logistic companies in the country. Huge investments are possible in China, as the country holds the largest share in raw material manufacturing for pharmaceutical drugs. India is also surveyed as the most lucrative markets owing to government favored policies in packaging industry and introduction of various schemes under government for cold chain logistics.

Global Pharmaceutical Cold Chain Packaging Market: Competitive Players

The prominent players in the global pharmaceutical cold chain packaging market include

• Sonoco ThermoSafe
• Coldchain Technologies
• Sealed Air Corporation
• Insulated Product Corp.
• CSafe Global LLC
• Global Cooling, Inc.
• Cryopak
• Envirotainer AB
• Biobase Group
• Haier Biomedical Co. Ltd.
• Dhruvraj Syndicate
• Valor Industries
• Allwin Roto Plast
• Blue Star Ltd.
• Pelican Biothermal LLC, Tamai Kasei Co., Ltd.
• WoolCool Ltd.
• KODIAKOOLER
• DGP Intelsius LLC
• TemperPack Technologies, Inc.
• Softbox Systems
• among others.

The Global Pharmaceutical Cold Chain Packaging Market segments are as follows:

By Packaging Format

• active
• passive packaging.

By Product Type

• small boxes
• pallets
• large sized pallet containers.

By Material

• polymers
• metals
• paper.

By Applications

• biologics & biological samples
• vaccines & diagnostics
• others.

By End-User

• diagnostic centers
• clinical research organizations
• blood banks
• the vaccine packaging industry
• pharmaceuticals
• other healthcare units.

Global Pharmaceutical Cold Chain Packaging Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonies to companies in order to fortify their foothold in the market.